Gil Hakim

Board Member

Gil Hakim is the Chairman and CEO of Armenta.

Gil has over 20 years of experience in executive positions in multinational med-tech, biotech and pharma industry companies. He previously served as the CEO and then president of UroGen Pharma (NASDAQ: URGN).  Prior to that, Gil was the director of new products development at Medispec Ltd., leading the research and development of novel medical devices using low intensity shockwaves to treat ischemic and inflammatory diseases. These products are currently in use worldwide.

B.Sc. in Life Sciences, from Ben-Gurion University